Delivery Order SPE2DB20D7059-SPE2DB25FGRQ0
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,793.24 by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. The contract is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and was competitively awarded with no set-aside designation. This award is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $21,254.05 and an ultimate completion date of August 20, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. As a major pharmaceutical distributor...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain for Ondansetron ODT 4mg tablets (30-count supply) valued at $48,173.20. The contract award, issued on August 25, 2025, with an ultimate completion date of September 22, 2025, utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction under AmerisourceBergen's existing...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Department of Defense's Medical Supply Chain for Ondansetron 8mg tablets (30-count supply) on August 4, 2025. The contract is valued at $1,141.98 and employs firm fixed pricing with no set-aside designation, indicating competitive award selection. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package. This is a non-set-aside, firm fixed-price contract with a ceiling value of $1,782.43 and a completion date of September 12, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,039.16 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the supply of Ondansetron Orally Disintegrating Tablet 8 mg in quantities of 30 tablets. This firm fixed-price delivery order, which is not set-aside, represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,795.50, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by August 28, 2025. The award was executed under AmerisourceBergen's...
- AmerisourceBergen Drug Corp received a $1,615.95 delivery order from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for Ondansetron ODT 8 mg tablets (30-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of August 20, 2025, and represents a child order under the company's larger contract vehicle with DLA. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,013.50 for Ondansetron Orally Disintegrating Tablets 8mg (30-count supply) on August 21, 2025, with completion targeted for September 18, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,911.52 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...